Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies.

Authors:
Müller K; Girl P; Giebl A; Gruetzner S; Antwerpen M and 3 more

Journal:
Virus Genes

Publication Year: 2021

DOI:
10.1007/s11262-021-01871-8

PMCID:
PMC8489549

PMID:
34608598

Journal Information

Full Title: Virus Genes

Abbreviation: Virus Genes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors declare no conflict of interest. Ethical approvalThe study was carried out in-line with “The Code of Ethics of the World Medical Association (Declaration of Helsinki)”. The use of serum samples complied with the guidelines of the Central Ethics Committee of the German Medical Association (Dtsch Arztebl 2003; 100(23): A-1632). In accordance with these guidelines, the anonymized use of residual material from the samples sent to our laboratory for diagnostic purposes is permissible, provided that the patients have not decided against this procedure. Samples from patients who had decided against this procedure were excluded from the analyses. Conflict of interest The authors declare no conflict of interest."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL. This study was funded by the Medical Biodefense Research Program of the Bundeswehr Medical Service."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025